Results 181 to 189 of about 231,796 (189)
Some of the next articles are maybe not open access.
The Role of CTCs as Tumor Biomarkers
2015Detection of Circulating Tumor Cells (CTCs) in peripheral blood can serve as a "liquid biopsy" approach and as a source of valuable tumor markers. CTCs are rare, and thus their detection, enumeration and molecular characterization are very challenging.
Evi Lianidou +2 more
openaire +3 more sources
Tumor biomarkers: PSA and beyond
Clinical Chemistry and Laboratory Medicine (CCLM), 2012Laboratory medicine plays an increasingly important role in the management of cancer patients (1, 2) . In none of the tumors has the advent of biomarkers changed the treatment in a more fundamental way than the introduction of prostate specifi c antigen (PSA) which has virtually transformed the management of prostate cancer.
openaire +3 more sources
Biomarkers in pancreatic neuroendocrine tumors.
Journal of Clinical Oncology, 2012166 Background: This study was designed to determine the role of Chromogranin A (CGA) and serotonin as prognostic biomarkers in relation with cytoreductive surgery for pancreatic neuroendocrine tumors (PNETs).The role of CGA and serotonin as biomarkers for PNETs is not fully established.
Randall F. Holcombe +4 more
openaire +2 more sources
Brain Tumor Biomarkers in Circulation
2016Molecular pathology of brain tumors. Circulating glioblastoma (GBM) epigenetic biomarkers. Circulating GBM miRNA biomarkers. Serum GBM protein biomarkers. Circulating GBM cells. Circulating endothelial and endothelial progenitor cells.
openaire +2 more sources
Tumor Biomarkers Guide Immunotherapy
Genetic Engineering & Biotechnology News, 2017openaire +2 more sources